[HTML][HTML] Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review

VN Dahl, M Mølhave, A Fløe, J van Ingen… - International Journal of …, 2022 - Elsevier
Objectives To describe the global trends of pulmonary nontuberculous mycobacteria (NTM)
infection and disease. Methods A systematic review of studies including culture-based NTM …

Inhaled medicines: past, present, and future

S Anderson, P Atkins, P Bäckman, D Cipolla… - Pharmacological …, 2022 - ASPET
The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease

RM Dedrick, BE Smith, M Cristinziano… - Clinical infectious …, 2023 - academic.oup.com
Abstract Background Nontuberculous Mycobacterium infections, particularly Mycobacterium
abscessus, are increasingly common among patients with cystic fibrosis and chronic …

[HTML][HTML] Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection

JA Nick, RM Dedrick, AL Gray, EK Vladar, BE Smith… - Cell, 2022 - cell.com
Two mycobacteriophages were administered intravenously to a male with treatment-
refractory Mycobacterium abscessus pulmonary infection and severe cystic fibrosis lung …

[图书][B] WHO operational handbook on tuberculosis. Module 4: treatment-drug-susceptible tuberculosis treatment

World Health Organization - 2021 - books.google.com
Page 1 WHO Module 4: Treatment Drug-susceptible tuberculosis treatment operational
handbook on tuberculosis World Health Organization Page 2 WHO operationa handbook …

A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American …

JM Miller, MJ Binnicker, S Campbell… - Clinical Infectious …, 2018 - academic.oup.com
The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a
close, positive working relationship between the physician/advanced practice provider and …

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus

K To, R Cao, A Yegiazaryan, J Owens… - Journal of clinical …, 2020 - mdpi.com
Nontuberculous mycobacteria (NTM) are emerging human pathogens, causing a wide
range of clinical diseases affecting individuals who are immunocompromised and who have …

Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases

C Lange, EC Böttger, E Cambau, DE Griffith… - The Lancet Infectious …, 2022 - thelancet.com
The 2020 clinical practice guideline for the treatment of non-tuberculous mycobacterial
pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory …

Treatment of Mycobacterium abscessus pulmonary disease

DE Griffith, CL Daley - Chest, 2022 - Elsevier
Mycobacterium abscessus is the second most common nontuberculous mycobacterial lung
disease pathogen and comprises three subspecies: abscessus, massiliense, and bolletii …

Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review

DR Prevots, JE Marshall, D Wagner… - Clinics in Chest …, 2023 - chestmed.theclinics.com
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease Page 1 Global
Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review D. Rebecca …